SCHEMBL9856415

SCHEMBL9856415

C#CN1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL717282 0.88 BRD4 (0.35)
SCHEMBL1509176 0.71
SCHEMBL6693515 0.69
SCHEMBL1414198 0.67
SCHEMBL8660593 0.65
SCHEMBL12633322 0.65
SCHEMBL11726006 0.63 CHRM2 (0.48)
SCHEMBL15044829 0.63 PARL (0.33)
SCHEMBL723636 0.62
SCHEMBL8993988 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3253377-B1 MONOMETHYLFUMARATE PRODRUG COMPOSITIONS ALKERMES PHARMA IRELAND LTD (IE) 2021-05-12 EP claimed
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP claimed
EP-0263492-B1 RETINOIDS, THEIR PREPARATION AND USE AS PHARMACEUTICAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 1991-03-13 EP claimed